Business ❯Pharmaceuticals ❯Biotechnology

Drug Development

Market Access Molecular Glue Degraders Evotec SE Regulatory Affairs Obesity Treatments Collaboration Bispecific Antibodies Clinical Research Acquisitions

Merck to Acquire Verona Pharma in $10 Billion Deal for Ohtuvayre COPD Therapy

The move positions Merck to integrate the fast-growing Ohtuvayre COPD therapy into its pipeline to help offset looming Keytruda revenue losses.

Cidara’s CD388 Antiviral Achieves Up to 76% Flu Protection in Phase 2b Trial

Pfizer Secures $6 Billion Licensing Deal for Chinese Cancer Drug SSGJ-707

Novo Nordisk Partners with Septerna in $2.2 Billion Deal for Oral Obesity Therapies

Monte Rosa Therapeutics' Stock Soars After $2.1 Billion Deal with Novartis

Rwanda Battles Deadly Marburg Virus Outbreak